An introduction to pharmacovigilance by patrick waller

7.07  ·  6,399 ratings  ·  191 reviews
Posted on by
an introduction to pharmacovigilance by patrick waller

An Introduction to Pharmacovigilance by Patrick Waller

Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems.


This introductory guide is designed to aid the rapid understanding of the key principles of pharmacovigilance. Packed full of examples illustrating drug safety issues it not only covers the processes involved, but the regulatory aspects and ethical and societal considerations of pharmacovigilance.

Covering the basics step-by-step, this book is perfect for beginners and is essential reading for those new to drug safety departments and pharmaceutical medicine students. The second edition is thoroughly revised and updated throughout and includes a new chapter on clinical aspects of pharmacovigilance.
File Name: an introduction to pharmacovigilance by patrick waller.zip
Size: 85000 Kb
Published 15.12.2018

Methods in Pharmacovigilance

Register for a free account

Colleague's E-mail is Invalid. Your message has been successfully sent to your colleague. Save my selection. The second edition of An Introduction to Pharmacovigilance describes the pharmacovigilance organization of health systems worldwide and, in particular, in the United States and Europe. The authors of the second edition of this guide have considerable experience in the field of pharmacovigilance. He then worked in the field of pharmacovigilance for the Medicines Control Agency in London and from to as an independent consultant in pharmacovigilance and pharmacoepidemiology. Mira Harrison-Woolrych is an honorary research associate professor of the Dunedin School of Medicine.

Account Options

Goodreads helps you keep track of books you want to read. Want to Read saving…. Want to Read Currently Reading Read. Other editions. Enlarge cover.

2 thoughts on “An Introduction to Pharmacovigilance by Patrick Waller

Leave a Reply